AKT1
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules (NCT01226316) | AstraZeneca | 2010-12-01 |
Track AKT1 automatically
Every clearance here is in the API, with alerts when new ones post.